{"title": [{"text": "Macquarie University at BioASQ 5b -Query-based Summarisation Techniques for Selecting the Ideal Answers", "labels": [], "entities": [{"text": "Macquarie University at BioASQ 5b", "start_pos": 0, "end_pos": 33, "type": "DATASET", "confidence": 0.9012862563133239}]}], "abstractContent": [{"text": "Macquarie University's contribution to the BioASQ challenge (Task 5b Phase B) fo-cused on the use of query-based extractive summarisation techniques for the generation of the ideal answers.", "labels": [], "entities": [{"text": "BioASQ challenge (Task 5b Phase B)", "start_pos": 43, "end_pos": 77, "type": "DATASET", "confidence": 0.6983069032430649}]}, {"text": "Four runs were submitted, with approaches ranging from a trivial system that selected the first n snippets, to the use of deep learning approaches under a regression framework.", "labels": [], "entities": []}, {"text": "Our experiments and the ROUGE results of the five test batches of BioASQ indicate surprisingly good results for the trivial approach.", "labels": [], "entities": [{"text": "ROUGE", "start_pos": 24, "end_pos": 29, "type": "METRIC", "confidence": 0.9983685612678528}, {"text": "BioASQ", "start_pos": 66, "end_pos": 72, "type": "DATASET", "confidence": 0.6477475166320801}]}, {"text": "Overall, most of our runs on the first three test batches achieved the best ROUGE-SU4 results in the challenge.", "labels": [], "entities": [{"text": "ROUGE-SU4", "start_pos": 76, "end_pos": 85, "type": "METRIC", "confidence": 0.997391939163208}]}], "introductionContent": [{"text": "The main goal of query-focused multi-document summarisation is to summarise a collection of documents from the point of view of a particular query.", "labels": [], "entities": [{"text": "multi-document summarisation", "start_pos": 31, "end_pos": 59, "type": "TASK", "confidence": 0.5056139379739761}, {"text": "summarise a collection of documents", "start_pos": 66, "end_pos": 101, "type": "TASK", "confidence": 0.8393024682998658}]}, {"text": "In this paper we compare the use of various techniques for query-focused summarisation within the context of the BioASQ challenge.", "labels": [], "entities": [{"text": "summarisation", "start_pos": 73, "end_pos": 86, "type": "TASK", "confidence": 0.6797906160354614}, {"text": "BioASQ challenge", "start_pos": 113, "end_pos": 129, "type": "TASK", "confidence": 0.5996167659759521}]}, {"text": "The BioASQ challenge ( started in 2013 and it comprises various tasks centred on biomedical semantic indexing and question answering.", "labels": [], "entities": [{"text": "biomedical semantic indexing", "start_pos": 81, "end_pos": 109, "type": "TASK", "confidence": 0.7185429533322653}, {"text": "question answering", "start_pos": 114, "end_pos": 132, "type": "TASK", "confidence": 0.855965793132782}]}, {"text": "The fifth run of the BioASQ challenge (), in particular, had three tasks: \u2022 BioASQ 5a: Large-scale online biomedical semantic indexing.", "labels": [], "entities": [{"text": "Large-scale online biomedical semantic indexing", "start_pos": 87, "end_pos": 134, "type": "TASK", "confidence": 0.5932004034519196}]}, {"text": "\u2022 BioASQ 5b: Biomedical semantic question answering.", "labels": [], "entities": [{"text": "BioASQ 5b", "start_pos": 2, "end_pos": 11, "type": "DATASET", "confidence": 0.6649728268384933}, {"text": "Biomedical semantic question answering", "start_pos": 13, "end_pos": 51, "type": "TASK", "confidence": 0.8709085136651993}]}, {"text": "This task had two phases: -Phase A: Identification of relevant information.", "labels": [], "entities": [{"text": "Identification of relevant information", "start_pos": 36, "end_pos": 74, "type": "TASK", "confidence": 0.9055908620357513}]}, {"text": "-Phase B: Question answering.", "labels": [], "entities": [{"text": "Question answering", "start_pos": 10, "end_pos": 28, "type": "TASK", "confidence": 0.9178087711334229}]}, {"text": "\u2022 BioASQ 5c: Funding information extraction from biomedical literature.", "labels": [], "entities": [{"text": "BioASQ 5c", "start_pos": 2, "end_pos": 11, "type": "DATASET", "confidence": 0.7051027417182922}, {"text": "Funding information extraction from biomedical literature", "start_pos": 13, "end_pos": 70, "type": "TASK", "confidence": 0.8073541522026062}]}, {"text": "The questions used in BioASQ 5b were of three types: yes/no, factoid, list, and summary.", "labels": [], "entities": [{"text": "BioASQ 5b", "start_pos": 22, "end_pos": 31, "type": "DATASET", "confidence": 0.8301983773708344}]}, {"text": "Submissions to the challenge needed to provide an exact answer and an ideal answer.", "labels": [], "entities": []}, {"text": "shows examples of exact and ideal answers for each type of question.", "labels": [], "entities": []}, {"text": "We can see that the ideal answers are full sentences that expand the information provided by the exact answers.", "labels": [], "entities": []}, {"text": "These ideal answers could be seen as the result of query-focused multidocument summarisation.", "labels": [], "entities": []}, {"text": "We therefore focused on Task 5b Phase B, and in that phase we did not attempt to provide exact answers.", "labels": [], "entities": []}, {"text": "Instead, our runs provided the ideal answers only.", "labels": [], "entities": []}, {"text": "In this paper we will describe the techniques and experiment results that were most relevant to our final system runs.", "labels": [], "entities": []}, {"text": "Some of our runs were very simple, yet our preliminary experiments revealed that they were very effective and, as expected, the simpler approaches were much faster than the more complex approaches.", "labels": [], "entities": []}, {"text": "Each of the questions in the BioASQ test sets contained the text of the question, the question type, a list of source documents, and a list of relevant snippets from the source documents.", "labels": [], "entities": [{"text": "BioASQ test sets", "start_pos": 29, "end_pos": 45, "type": "DATASET", "confidence": 0.8914625644683838}]}, {"text": "We used this information, plus the source documents which are PubMed abstracts accessible using the URL provided in the test sets.", "labels": [], "entities": []}, {"text": "Overall, the summarisation process of our runs consisted of the following two steps: 1.", "labels": [], "entities": [{"text": "summarisation", "start_pos": 13, "end_pos": 26, "type": "TASK", "confidence": 0.9554376602172852}]}, {"text": "Split the input text (source documents or snippets) into candidate sentences and score each candidate sentence.", "labels": [], "entities": []}, {"text": "2. Return then sentences with highest score.", "labels": [], "entities": [{"text": "Return", "start_pos": 3, "end_pos": 9, "type": "METRIC", "confidence": 0.9324236512184143}]}, {"text": "The value of n was determined empirically and it depended on the question type, as shown in Table 1.", "labels": [], "entities": []}, {"text": "yes/no Does Apolipoprotein E (ApoE) have anti-inflammatory activity?", "labels": [], "entities": [{"text": "Apolipoprotein E (ApoE)", "start_pos": 12, "end_pos": 35, "type": "METRIC", "confidence": 0.9371201038360596}]}, {"text": "\u2022 Exact answer: yes \u2022 Ideal answer: Yes.", "labels": [], "entities": [{"text": "Ideal answer", "start_pos": 22, "end_pos": 34, "type": "METRIC", "confidence": 0.9129116535186768}]}, {"text": "ApoE has anti-inflammatory activity factoid Which type of lung cancer is afatinib used for?", "labels": [], "entities": [{"text": "ApoE", "start_pos": 0, "end_pos": 4, "type": "METRIC", "confidence": 0.9805575609207153}]}, {"text": "\u2022 Exact answer: EGFR-mutant non small cell lung carcinoma \u2022 Ideal answer: Afatinib is a small molecule covalently binding and inhibiting the EGFR, HER2 and HER4 receptor tyrosine kinases.", "labels": [], "entities": [{"text": "Ideal", "start_pos": 60, "end_pos": 65, "type": "METRIC", "confidence": 0.9815973043441772}]}, {"text": "Trials showed promising efficacy in patients with EGFRmutant NSCLC or enriched for clinical benefit from EGFR tyrosine kinase inhibitors gefitinib or erlotinib.", "labels": [], "entities": []}, {"text": "list Which are the Yamanaka factors?", "labels": [], "entities": []}, {"text": "\u2022 Exact answer: [OCT4, SOX2, MYC, KLF4] \u2022 Ideal answer: The Yamanaka factors are the OCT4, SOX2, MYC, and KLF4 transcription factors summary What is the role of brain natriuretic peptide in traumatic brain injury patients ? \u2022 Exact answer: N/A \u2022 Ideal answer: Brain natriuretic peptide concentrations are elevated in patients with traumatic brain during the acute phase and correlate with poor outcomes.", "labels": [], "entities": []}, {"text": "In traumatic brain injury patients higher brain natriuretic peptide concentrations are associated with more extensive SAH, elevated ICP and hyponatremia.", "labels": [], "entities": [{"text": "SAH", "start_pos": 118, "end_pos": 121, "type": "METRIC", "confidence": 0.9849146604537964}, {"text": "ICP", "start_pos": 132, "end_pos": 135, "type": "METRIC", "confidence": 0.9853883385658264}]}, {"text": "Brain natriuretic peptide may play an adaptive role in recovery through augmentation of cerebral blood flow.: Value of n (the number of sentences returned as the ideal answer) for each question type.", "labels": [], "entities": []}], "datasetContent": [], "tableCaptions": [{"text": " Table 1: Value of n (the number of sentences re- turned as the ideal answer) for each question type.", "labels": [], "entities": []}, {"text": " Table 2: ROUGE-SU4 of the simple runs.", "labels": [], "entities": [{"text": "ROUGE-SU4", "start_pos": 10, "end_pos": 19, "type": "METRIC", "confidence": 0.9843686819076538}]}, {"text": " Table 3: Average MSE of 10-fold cross-validation.", "labels": [], "entities": [{"text": "MSE", "start_pos": 18, "end_pos": 21, "type": "METRIC", "confidence": 0.7443034052848816}]}]}